The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study
Official Title: Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact
Study ID: NCT05895279
Brief Summary: This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.
Detailed Description: PRIMARY OBJECTIVE: I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM). OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.
Minimum Age: 35 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Mayo Clinic in Florida, Jacksonville, Florida, United States
Name: Folakemi T. Odedina, Ph.D.
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR